Arnd Nusch

6.6k citations
53 papers · 4.7k · 4 hit papers · h-index 21

Impact in

    • Advanced Breast Cancer Therapies
  • Oncology top 1%
    • Cancer-related Molecular Pathways
    • HER2/EGFR in Cancer Research
    • Cancer Treatment and Pharmacology
    • Colorectal Cancer Treatments and Studies

Papers in

    • Advanced Breast Cancer Therapies 17
    • Lung Cancer Treatments and Mutations 7
    • Cancer Treatment and Pharmacology 7
    • Colorectal Cancer Treatments and Studies 5
    • Cancer Immunotherapy and Biomarkers 3

Arnd Nusch

47 papers receiving 4.6k citations

Arnd Nusch's Hit Papers

Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survival 2021 · 200 citations
2000+3+6Years since publication50010001.5k

Peers

Arnd Nusch
Comparison fields: 5 of 89
  • Pulmonary and Respiratory Medicine 3.2k
  • Oncology 2.2k
  • Cancer Research 776
  • Genetics 544
  • Hepatology 262
Replace Arunee Dechaphunkul with:
Arunee Dechaphunkul Thailand
Christian Scheffold United States
Mark S. Huberman United States
G.S. Bhattacharyya India
Cristian Massacesi Italy
Jin‐Ji Yang China
N. Moore Switzerland
R. Corre France
Zachary Rockow Chalmers United States
H. Léna France
Arnd Nusch relative to Arunee Dechaphunkul Thailand Arunee Dechaphunkul's profile →
Citations per field
00.5×2×4×6×7.5×
Arunee Dechaphunkul · 1×
Citations per year

Countries citing papers authored by Arnd Nusch

Since Specialization
Citations

This map shows the geographic impact of Arnd Nusch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnd Nusch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnd Nusch more than expected).

Fields of papers citing papers by Arnd Nusch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arnd Nusch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnd Nusch. The network helps show where Arnd Nusch may publish in the future.

Co-authors

The 25 scholars most cited alongside Arnd Nusch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Arnd Nusch Line = papers co-authored together Arnd Nusch links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer
Hit paper breakdown →
20161544
2
Phase III Randomized Study of Ribociclib and Fulvestrant in Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: MONALEESA-3
Hit paper breakdown →
2018868
3
Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer
Hit paper breakdown →
2019606
4 2017283
5
Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survival
Hit paper breakdown →
2021200
6 2015191
7 2015142
8 201386
9 202073
10 200369
11 202064
12 199262
13 201851
14 202351
15 201647
16 201042
17 201741
18 202032
19 202329
20 201724

About Arnd Nusch

Arnd Nusch is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Genetics and Pathology and Forensic Medicine, having authored 53 papers that have together received 4.7k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (17 papers), Cancer Treatment and Pharmacology (7 papers), Lung Cancer Treatments and Mutations (7 papers), Colorectal Cancer Treatments and Studies (5 papers), Chronic Lymphocytic Leukemia Research (4 papers), Cancer Genomics and Diagnostics (3 papers), Breast Cancer Treatment Studies (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (3.2k citations), Oncology (2.2k citations), Cancer Research (776 citations), Genetics (544 citations) and Hepatology (262 citations). Arnd Nusch has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Joseph Thaddeus Beck, Patrick Neven, Norbert Walter Marschner, Guy Jérusalem, Giulia Bianchi, Peter Andreas Fasching, Martina Jänicke, Katarína Petráková, Dennis J. Slamon and Gabe S. Sonke. Their work appears in journals such as Annals of Oncology, Blood, International Journal of Cancer, Journal of Clinical Oncology and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact